Alzheimer's disease affects millions globally, with many more at risk in the preclinical stages. While the exact mechanism of the disease remains unclear, recent research suggests that various clinical, genetic, and lifestyle-related risk factors significantly increase the likelihood of developing Alzheimer's. Early intervention targeting these factors could slow disease progression by up to 40%.